| Literature DB >> 27366752 |
Leo Pruimboom1, Begoña Ruiz-Núñez2, Charles L Raison3, Frits A J Muskiet2.
Abstract
Chronic low-grade inflammation and insulin resistance are intimately related entities that are common to most, if not all, chronic diseases of affluence. We hypothesized that a short-term intervention based on "ancient stress factors" may improve anthropometrics and clinical chemical indices. We executed a pilot study of whether a 10-day mimic of a hunter-gatherer lifestyle favorably affects anthropometrics and clinical chemical indices. Fifty-five apparently healthy subjects, in 5 groups, engaged in a 10-day trip through the Pyrenees. They walked 14 km/day on average, carrying an 8-kilo backpack. Raw food was provided and self-prepared and water was obtained from waterholes. They slept outside in sleeping bags and were exposed to temperatures ranging from 12 to 42°C. Anthropometric data and fasting blood samples were collected at baseline and the study end. We found important significant changes in most outcomes favoring better metabolic functioning and improved anthropometrics. Coping with "ancient mild stress factors," including physical exercise, thirst, hunger, and climate, may influence immune status and improve anthropometrics and metabolic indices in healthy subjects and possibly patients suffering from metabolic and immunological disorders.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27366752 PMCID: PMC4913061 DOI: 10.1155/2016/6935123
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Anthropometrics and clinical chemical indices at baseline and at the study end.
| Unit |
| Baseline | Study end | Change |
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | Range | Median | Range | Median | Range | SD | 95% CI of the mean | ||||
| Body weight | kg | 55 | 68.0 | 48.4–116.3 | 65.00 | 46.9–111.8 | −3.8 | −12.5 to −0.7 | 2.0 | −4.4 to −3.3 | <0.001 |
| Age | Years | 50 | 38 | 22–67 | NM | NM | NM | NM | NM | NM | NM |
| Height | cm | 55 | 175 | 154–203 | NM | NM | NM | NM | NM | NM | NM |
| BMI | kg/m2 | 55 | 22.40 | 17.4–31.9 | 21.3 | 16.8–30.4 | −1.2 | −4.4 to −0.2 | 0.6 | −1.4 to −1.1 | <0.001 |
| Hip circumference | cm | 44 | 100 | 85–120 | 96 | 86–115 | −3 | −17 to 5 | 3.3 | −4.2 to −2.2 | <0.001 |
| Waist circumference | cm | 44 | 81 | 66–110 | 76 | 63–101 | −5 | −18 to 9 | 5.5 | −7 to −4 | <0.001 |
| Waist/hip ratio | cm/cm | 44 | 0.84 | 0.72–1.00 | 0.80 | 0.66–0.94 | −0.02 | −0.14 to 0.10 | 0.06 | −0.04 to −0.02 | 0.002 |
|
| |||||||||||
| Glucose | mmol/L | 53 | 4.9 | 4.2–5.8 | 4.3 | 3.3–6.1 | −0.6 | −1.7 to 0.5 | 0.6 | −0.8 to −0.5 | <0.001 |
| HbA1c | % | 53 | 5.3 | 4.8–6.1 | 5.3 | 4.7–6.1 | −0.1 | −0.4 to 0.2 | 0.2 | −0.1 to −0.05 | <0.001 |
| Insulin | mU/L | 23 | 14.0 | 3.7–36.8 | 6.7 | 1.1–12.9 | −4.7 | −31.4 to −0.2 | 8.1 | −12.2 to −5.2 | <0.001 |
| HOMA-IR | mmol | 22 | 3.0 | 0.8–7.9 | 1.4 | 0.2–2.6 | −1.2 | −7.0 to −0.4 | 1.8 | −2.8 to −1.3 | <0.001 |
|
| |||||||||||
| Triglycerides | mmol/L | 53 | 0.69 | 0.34–6.68 | 0.52 | 0.37–2.77 | −0.14 | −6.12 to 2.18 | 0.92 | −0.52 to −0.01 | <0.001 |
| Total cholesterol | mmol/L | 53 | 5.2 | 3.2–8.2 | 4.5 | 2.6–8.1 | −0.7 | −2.8 to 0.4 | 0.7 | −1.0 to −0.6 | <0.001 |
| HDL-cholesterol | mmol/L | 53 | 2.0 | 0.7–3.1 | 1.9 | 1.0–3.5 | 0.0 | −0.8 to 0 .6 | 0.3 | −0.1 to 0.1 | 0.464 |
| LDL-cholesterol | mmol/L | 52 | 3.0 | 1.3–5.8 | 2.5 | 0.0–5.4 | −0.6 | −3.1 to 0.6 | 0.7 | −0.8 to −0.5 | <0.001 |
| TG/HDL-cholesterol ratio | mol/mol | 53 | 0.3 | 0.16–9.54 | 0.26 | 0.11–1.73 | −0.55 | −8.98 to 1.34 | 1.3 | −0.59 to 0.98 | <0.001 |
|
| |||||||||||
| ASAT | IU/L | 53 | 22 | 14–52 | 33 | 11–75 | 11 | −8 to 54 | 11.4 | 9 to 15 | <0.001 |
| ALAT | IU/L | 53 | 20 | 11–42 | 25 | 12–47 | 6.0 | −13 to 52 | 7.3 | 5 to 9 | <0.001 |
| CRP | mg/L | 42 | 0.61 | 0.14–27.04 | 1.36 | 0.14–41.65 | 0.56 | −15.72 to 41.07 | 8.45 | 0.20 to 5.46 | <0.001 |
|
| |||||||||||
| TSH | mU/L | 42 | 1.25 | 0.02–3.12 | 1.11 | 0.02–4.40 | −0.08 | −0.93 to 1.28 | 0.47 | −0.19 to −0.10 | 0.326 |
| FT4 | pmol/L | 42 | 10.8 | 7.9–19.4 | 11.3 | 7.8–20.6 | 0.1 | −5.6 to 8.4 | 2.3 | −0.4 to 1.1 | 0.378 |
| FT3 | pmol/L | 42 | 4.4 | 2.3–6.5 | 3.5 | 1.7–8.7 | −0.8 | −3.4 to 3.1 | 1.0 | −1.0 to −0.5 | <0.001 |
Data are medians (range). ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; BMI, body mass index; CRP, C-reactive protein; FT3, free triiodothyronine; FT4, free thyroxine; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-estimated insulin resistance; LDL, low-density lipoprotein; NM, not measured; TG, triglycerides; TSH, thyroid-stimulating hormone. Significant difference between the values before and after the intervention by Wilcoxon signed rank test at p < 0.05.
Figure 1Median and individual changes of ASAT (a), ALAT (b), and CRP (c) during the 10-day trip through the Pyrenees.
Figure 2Medians of the percentage changes of anthropometric and clinical chemical parameters during the 10-day trip through the Pyrenees. Only significant changes are shown (see Table 1). For abbreviations see the footnote of Table 1.